Free Trial
NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

$4.02
+0.10 (+2.55%)
(As of 07/26/2024 ET)
Today's Range
$3.92
$4.04
50-Day Range
$3.67
$4.71
52-Week Range
$3.63
$15.08
Volume
171,509 shs
Average Volume
389,281 shs
Market Capitalization
$82.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

PetMed Express MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
30.6% Upside
$5.25 Price Target
Short Interest
Healthy
10.74% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.72mentions of PetMed Express in the last 14 days
Based on 13 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.28) to ($0.12) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.58 out of 5 stars

Retail/Wholesale Sector

140th out of 201 stocks

Drug Stores & Proprietary Stores Industry

3rd out of 4 stocks

PETS stock logo

About PetMed Express Stock (NASDAQ:PETS)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Stock Price History

PETS Stock News Headlines

We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
PetMed Express, Inc. Sets Fiscal First Quarter 2025 Earnings Call
PetMed Express (PETS) Earnings Dates & Reports
Reptile Super Show preview
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
PetMed Express Q4 Earnings Preview
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/11/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/06/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
210
Year Founded
1996

Price Target and Rating

Average Stock Price Target
$5.25
High Stock Price Target
$7.00
Low Stock Price Target
$3.50
Potential Upside/Downside
+32.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-7,460,000.00
Pretax Margin
-2.23%

Debt

Sales & Book Value

Annual Sales
$281.06 million
Cash Flow
$0.02 per share
Book Value
$4.57 per share

Miscellaneous

Free Float
20,380,000
Market Cap
$81.62 million
Optionable
Optionable
Beta
0.73

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Ms. Christine Chambers (Age 46)
    CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary
    Comp: $305.4k
  • Mr. Mark Moseley
    Chief Technology & Information Officer
  • Mr. Daniel Job Pingree
    Chief Marketing Officer
  • Ms. Jacqueline Smith
    Vice President of People
  • Wendy Zalai
    Corporate Controller & Corporate Secretary

PETS Stock Analysis - Frequently Asked Questions

How have PETS shares performed this year?

PetMed Express' stock was trading at $7.56 at the beginning of 2024. Since then, PETS shares have decreased by 46.8% and is now trading at $4.02.
View the best growth stocks for 2024 here
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its earnings results on Tuesday, June, 11th. The company reported ($0.25) earnings per share for the quarter. The company earned $66.50 million during the quarter. PetMed Express had a negative net margin of 2.85% and a negative trailing twelve-month return on equity of 7.09%.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are PetMed Express' major shareholders?

PetMed Express' top institutional investors include Profit Investment Management LLC (0.39%) and SG Americas Securities LLC (0.06%). Insiders that own company stock include Mathew N Hulett, Gian Fulgoni and Christine Chambers.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD) and Advanced Micro Devices (AMD).

This page (NASDAQ:PETS) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners